Docket #: S02-234
Deriving Pure Compositions of Mammalian Megakaryocyte Progenitor Cells
Please see issued patent and publication, below, for details.
Publications
Patents
- Published Application: 20050176142
Similar Technologies
-
Systemic targeting of inflammatory sites and enhanced immunomodulatory function by introducing the chimeric antigen receptor (CAR) into mesenchymal stem cells for inflammatory and autoimmune diseases S17-417Systemic targeting of inflammatory sites and enhanced immunomodulatory function by introducing the chimeric antigen receptor (CAR) into mesenchymal stem cells for inflammatory and autoimmune diseases
-
SMASh_CARs: A "drug off" chemogenetic system for regulating CAR T-cell therapy S17-501SMASh_CARs: A "drug off" chemogenetic system for regulating CAR T-cell therapy
-
Transiently Regulated CAR-T Cells Engineered to Prevent T-cell Exhaustion and Improve Immunotherapy S17-119Transiently Regulated CAR-T Cells Engineered to Prevent T-cell Exhaustion and Improve Immunotherapy